Labcorp Holdings Inc. Files 8-K on Financials
Ticker: LH · Form: 8-K · Filed: Aug 1, 2024 · CIK: 920148
| Field | Detail |
|---|---|
| Company | Labcorp Holdings Inc. (LH) |
| Form Type | 8-K |
| Filed Date | Aug 1, 2024 |
| Risk Level | low |
| Pages | 1 |
| Reading Time | 2 min |
| Key Dollar Amounts | $0.10 |
| Sentiment | neutral |
Sentiment: neutral
Topics: financial-reporting, 8-k
TL;DR
Labcorp dropped an 8-K on Aug 1st covering their financials. Check it out.
AI Summary
Labcorp Holdings Inc. filed an 8-K on August 1, 2024, reporting on its results of operations and financial condition. The filing includes financial statements and exhibits, with the company's principal executive offices located at 358 South Main Street, Burlington, North Carolina.
Why It Matters
This filing provides an update on Labcorp's financial performance and condition, which is crucial for investors to assess the company's health and future prospects.
Risk Assessment
Risk Level: low — This is a routine financial filing and does not appear to contain any immediately alarming information.
Key Players & Entities
- LABCORP HOLDINGS INC. (company) — Filer
- 358 South Main Street, Burlington, North Carolina 27215 (location) — Principal executive offices address
- August 01, 2024 (date) — Date of earliest event reported
FAQ
What specific financial information is being reported in this 8-K?
The filing indicates it covers 'Results of Operations and Financial Condition' and includes 'Financial Statements and Exhibits'.
When was the earliest event reported in this filing?
The earliest event reported is August 01, 2024.
What is the primary business of Labcorp Holdings Inc. according to the filing?
The filing lists the Standard Industrial Classification as 'SERVICES-MEDICAL LABORATORIES [8071]'.
Where are Labcorp Holdings Inc.'s principal executive offices located?
The principal executive offices are located at 358 South Main Street, Burlington, North Carolina 27215.
What is the SEC file number for Labcorp Holdings Inc.?
The SEC file number is 001-11353.
Filing Stats: 377 words · 2 min read · ~1 pages · Grade level 11.6 · Accepted 2024-08-01 07:04:28
Key Financial Figures
- $0.10 — nge on which registered Common Stock , $0.10 par value LH New York Stock Exchange
Filing Documents
- lh-20240801.htm (8-K) — 24KB
- form8-kerex991for2q24.htm (EX-99.1) — 349KB
- labcorp_logoxhorizontalxcoa.jpg (GRAPHIC) — 108KB
- 0000920148-24-000096.txt ( ) — 663KB
- lh-20240801.xsd (EX-101.SCH) — 2KB
- lh-20240801_lab.xml (EX-101.LAB) — 22KB
- lh-20240801_pre.xml (EX-101.PRE) — 13KB
- lh-20240801_htm.xml (XML) — 3KB
02 Results of Operations and Financial Condition
Item 2.02 Results of Operations and Financial Condition
01 Financial Statements and Exhibits
Item 9.01 Financial Statements and Exhibits. Exhibit Exhibit Name Exhibit 99.1 Press Release dated August 1, 2024 issued by Labcorp titled "Labcorp Announces 2024 Second Quarter Results"
SIGNATURES
SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. LABORATORY CORPORATION OF AMERICA HOLDINGS Registrant By: /s/ SANDRA VAN DER VAART Sandra van der Vaart Executive Vice President, Chief Legal Officer and Corporate Secretary August 01, 2024